Murck 2001.
| Trial name or title | A multicentre, double‐blind, randomised, parallel group, placebo‐controlled, dose‐ranging pilot study of ethyl‐eicosapentaenoate (ethyl‐EPA) in patients with schizophrenia. |
| Methods | Allocation: randomised. Blindness: double. |
| Participants | Diagnosis: schizophrenia. |
| Interventions | 1. Varied doses of E‐EPA. 2. Placebo. |
| Outcomes | |
| Starting date | |
| Contact information | |
| Notes |